UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study

Pujade-Lauraine, Eric; Fujiwara, Keiichi; Ledermann, Jonathan A; Oza, Amit M; Kristeleit, Rebecca; Ray-Coquard, Isabelle-Laure; Richardson, Gary E; ... Monk, Bradley J; + view all (2021) Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study. Obstetrical & Gynecological Survey , 76 (11) pp. 673-675. 10.1097/OGX.0000000000000980. Green open access

[thumbnail of JAV_Ovarian_200_Ms_Accepted.pdf]
Preview
Text
JAV_Ovarian_200_Ms_Accepted.pdf - Accepted Version

Download (8MB) | Preview

Abstract

The majority of patients with ovarian cancer will experience relapse and develop platinum-resistant disease after being treated with frontline platinum-based chemotherapy. Treatment options for platinum-resistance or platinum-refractory disease are very limited, usually involving nonplatinum chemotherapy, and they are associated with poor objective response rates and life expectancy.

Type: Article
Title: Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study
Open access status: An open access version is available from UCL Discovery
DOI: 10.1097/OGX.0000000000000980
Publisher version: https://doi.org/10.1097/OGX.0000000000000980
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10143082
Downloads since deposit
3,116Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item